Valtoco 15 MG nasal sprays
Ended Awarded
- Contract number
- SPE2DB25FN3PA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,129
Award facts
- Contract value 100% obligated
- $1,128.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 4, 2025. This firm fixed-price contract, issued on August 1, 2025, represents a non-set-aside competitive award with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor, particularly for Defense Health Agency and military healthcare programs. The company's portfolio of federal contracts demonstrates extensive experience delivering both brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Valtoco—an FDA-approved nasal spray for acute treatment of seizure clusters—reflects the company's capability to fulfill specialized pharmaceutical requirements for military and federal health systems through the DLA's established procurement framework.
Quick answers
Who was awarded contract SPE2DB25FN3PA?
SPE2DB25FN3PA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FN3PA worth?
The government has obligated $1,129 on SPE2DB25FN3PA.
Is contract SPE2DB25FN3PA an order under another contract?
Yes. SPE2DB25FN3PA is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3PA competed?
The extent of competition for SPE2DB25FN3PA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award